4.6 Article

Dexmedetomidine Alleviates Microglia-Induced Spinal Inflammation and Hyperalgesia in Neonatal Rats by Systemic Lipopolysaccharide Exposure

期刊

FRONTIERS IN CELLULAR NEUROSCIENCE
卷 15, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fncel.2021.725267

关键词

lipopolysaccharide-induced inflammation; spinal cord; hyperalgesia; microglia; dexmedetomidine

资金

  1. Shanghai Committee of Science and Technology [20ZR1434600]
  2. National Natural Science Foundation of China [81270414]
  3. Shanghai Municipal Commission of Health and Family Planning
  4. Key Developing Disciplines [2015ZB0106]

向作者/读者索取更多资源

Early life exposure to noxious stimulus and painful experiences can lead to cognitive deficits and abnormal pain sensitivity. Dexmedetomidine (DEX) has demonstrated neuroprotective effects by inhibiting microglial activation and pro-inflammatory cytokine expression, attenuating spinal inflammation and hyperalgesia induced by LPS. The findings suggest that DEX may serve as a protective agent in infection-induced hyperalgesia in neonates and preterm infants.
Noxious stimulus and painful experience in early life can induce cognitive deficits and abnormal pain sensitivity. As a major component of the outer membrane of gram-negative bacteria, lipopolysaccharide (LPS) injection mimics clinical symptoms of bacterial infections. Spinal microglial activation and the production of pro-inflammatory cytokines have been implicated in the pathogenesis of LPS-induced hyperalgesia in neonatal rats. Dexmedetomidine (DEX) possesses potent anti-neuroinflammatory and neuroprotective properties through the inhibition of microglial activation and microglial polarization toward pro-inflammatory (M1) phenotype and has been widely used in pediatric clinical practice. However, little is known about the effects of DEX on LPS-induced spinal inflammation and hyperalgesia in neonates. Here, we investigated whether systemic LPS exposure has persistent effects on spinal inflammation and hyperalgesia in neonatal rats and explored the protective role of DEX in adverse effects caused by LPS injection. Systemic LPS injections induced acute mechanical hyperalgesia, increased levels of pro-inflammatory cytokines in serum, and short-term increased expressions of pro-inflammatory cytokines and M1 microglial markers in the spinal cord of neonatal rats. Pretreatment with DEX significantly decreased inflammation and alleviated mechanical hyperalgesia induced by LPS. The inhibition of M1 microglial polarization and microglial pro-inflammatory cytokines expression in the spinal cord may implicate its neuroprotective effect, which highlights a new therapeutic target in the treatment of infection-induced hyperalgesia in neonates and preterm infants.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据